Concepedia
Statistics
Publications
2
Citations
95
H-Index
Active since
2020
Affiliations
RIKEN(Current)
Tokyo Institute of Technology
Pioneer (Japan)
Kazan Federal University
Pioneer (United States)
Ivan Smirnov is an author at RIKEN specializing in oncology, medicinal chemistry, and drug discovery.
Publications per year
2020–2022
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression
Igor Nasibullin, Ivan Smirnov, Peni Ahmadi et al. · Nature Communications · 2022 · 74 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +14
A Strategy for Tumor Targeting by Higher‐Order Glycan Pattern Recognition: Synthesis and In Vitro and In Vivo Properties of Glycoalbumins Conjugated with Four Different <i>N</i>‐Glycan Molecules
Ivan Smirnov, Regina Sibgatullina, Sayaka Urano et al. · Small · 2020 · 21 citations
Life Sciences, Medicinal Chemistry, Oncology +15
1–2 of 2